| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/02/1995 | WO1995006123A1 Detection and prevention of mycoplasma hominis infection |
| 03/02/1995 | WO1995006122A2 Recombinant alternaria alternata allergenes |
| 03/02/1995 | WO1995006121A2 Recombinant cladosporium herbarum allergens |
| 03/02/1995 | WO1995006120A1 Recombinant cells from the monocyte-macrophage cell line for gene therapy |
| 03/02/1995 | WO1995006118A1 Expression control sequences of the p-selectin gene |
| 03/02/1995 | WO1995006117A1 Human 5-ht2 receptor |
| 03/02/1995 | WO1995006116A1 Mammalian stromal cell proteins and dna sequences coding therefor |
| 03/02/1995 | WO1995006067A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 03/02/1995 | WO1995006066A1 Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor |
| 03/02/1995 | WO1995006065A1 Cytokines that bind the cell surface receptor hek |
| 03/02/1995 | WO1995006064A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i |
| 03/02/1995 | WO1995006063A1 Factor for fibroblast colony forming unit |
| 03/02/1995 | WO1995006062A1 Novel proteins isolated from nerve cells, dna sequences encoding same and usages thereof |
| 03/02/1995 | WO1995006059A1 Aqueous multiple-phase isolation of polypeptide |
| 03/02/1995 | WO1995006055A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
| 03/02/1995 | WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides |
| 03/02/1995 | WO1995005851A1 HIV vif-RELATED COMPOSITIONS, AND PROPHYLACTIC AND THERAPEUTIC USES THEREOF |
| 03/02/1995 | WO1995005850A1 Campylobacter jejuni antigens, and methods for their production and use |
| 03/02/1995 | WO1995005849A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 03/02/1995 | WO1995005847A1 Accessory factor function for interferon gamma and its receptor |
| 03/02/1995 | WO1995005836A1 Draculin, its method of preparation and use |
| 03/02/1995 | WO1995005835A1 Gene therapy for solid tumors, papillomas and warts |
| 03/02/1995 | WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 03/02/1995 | WO1995005750A1 Cell death regulator |
| 03/02/1995 | WO1995005738A1 Anticancer agents and apoptosis |
| 03/02/1995 | WO1995005732A1 Materials and methods for producing plants with single-sex flowers |
| 03/02/1995 | WO1995003418A3 Recombinant bcg vaccines |
| 03/02/1995 | WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 03/02/1995 | WO1995003410A3 Guanylatcyclase activating peptide i (gcap-i) coding gene |
| 03/02/1995 | WO1995001437A3 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 03/02/1995 | WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 03/02/1995 | DE4425481A1 Melanoma-inhibiting protein |
| 03/02/1995 | DE4325262A1 Resistance inducer, process for its preparation, use for controlling pests |
| 03/02/1995 | CA2623540A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 03/02/1995 | CA2170356A1 Recombinant cladosporium herbarum allergens |
| 03/02/1995 | CA2170355A1 Recombinant alternaria alternata allergenes |
| 03/02/1995 | CA2170352A1 Natural killer cell-specific antigen and antibodies that identify the same |
| 03/02/1995 | CA2170260A1 Fertile, transgenic maize plants and methods for their production |
| 03/02/1995 | CA2170159A1 Recombinant cells from the monocyte-macrophage cell ligne for gene therapy |
| 03/02/1995 | CA2169945A1 Factor for fibroblast colony forming unit |
| 03/02/1995 | CA2169941A1 Expression control sequences of the p-selectin gene |
| 03/02/1995 | CA2169851A1 Cytokines that bind the cell surface receptor hek |
| 03/02/1995 | CA2169849A1 Accessory factor function for interferon gamma and its receptor |
| 03/02/1995 | CA2169755A1 Detection and prevention of mycoplasma hominis infection |
| 03/02/1995 | CA2169748A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
| 03/02/1995 | CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 03/02/1995 | CA2168030A1 Molecular clones producing recombinant dna antigens of the hards virus |
| 03/02/1995 | CA2167691A1 Campylobacter jejuni antigens, and methods for their production and use |
| 03/01/1995 | EP0640690A1 Monoclonal antibodies specific for 5-dihydrotestosterone |
| 03/01/1995 | EP0640689A2 p40 Homodimer of interleukin-12 |
| 03/01/1995 | EP0640620A2 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic esterase receptor protein |
| 03/01/1995 | EP0640619A1 Erythropoietin analogs with additional glycosylation sites |
| 03/01/1995 | EP0640143A1 Senescent cell derived inhibitors of dna synthesis |
| 03/01/1995 | EP0640140A1 Yeast agglutination genes and yeast containing them |
| 03/01/1995 | EP0640137A1 Immortalized human cell lines containing exogenous cytochrome p450 genes |
| 03/01/1995 | EP0640135A1 Immunoglobulin binding proteins derived from l protein and their uses |
| 03/01/1995 | EP0640134A1 Protein l and process for its preparation by recombinant dna technology |
| 03/01/1995 | EP0640133A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 03/01/1995 | EP0640132A1 A method for controlling and determining plant organ morphogenesis, a homeotic gene, a promoter element therefor, and related uses thereof |
| 03/01/1995 | EP0640130A1 Chimeric multivalent protein analogues and methods of use thereof |
| 03/01/1995 | EP0640129A1 Inhibition of cell adhesion protein-carbohydrate interactions |
| 03/01/1995 | EP0640125A1 Improved recombinant protein production |
| 03/01/1995 | EP0640101A1 Methods and reagents for diagnosis of autoantibodies |
| 03/01/1995 | EP0640100A1 Modulation of thrombospondin-cd36 interactions |
| 03/01/1995 | EP0640098A1 Canine coronavirus s gene and uses therefor |
| 03/01/1995 | EP0640097A1 Compositions and methods for vaccination against coronaviruses |
| 03/01/1995 | EP0640096A1 Universal coronavirus vaccine |
| 03/01/1995 | EP0640094A1 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| 03/01/1995 | EP0640093A1 Human crabp-i and crabp-ii |
| 03/01/1995 | EP0639981A1 Igf-1 analogs |
| 03/01/1995 | EP0639980A1 Use of platelet derived growth factor in ophthalmic wound healing |
| 03/01/1995 | EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 03/01/1995 | EP0600018A4 Hepatitis c assay utilizing recombinant antigens to c-100 region. |
| 03/01/1995 | EP0600009A4 Hepatitis c assay utilizing recombinant antigens to ns1. |
| 03/01/1995 | EP0520011B1 Vaccines for preventing furunculosis in fish |
| 03/01/1995 | EP0485491B1 Artificial biological membrane |
| 03/01/1995 | EP0406428B1 Peptide derivatives and their use |
| 02/28/1995 | US5393873 Peptides with anticoagulant activity |
| 02/28/1995 | US5393870 Analogs of human granulocyte-macrophage colony stimulating factor |
| 02/28/1995 | US5393869 Polypeptides; hormone therapy for osteoporosis, hypertension and hypoparathyroidism |
| 02/28/1995 | US5393739 Use of bone morphogenetic protein in synergistic combination with TGF-β for bone repair |
| 02/28/1995 | US5393534 Liver-derived tumor cell growth inhibitor |
| 02/28/1995 | US5393523 Administering to protect against malaria |
| 02/28/1995 | CA1334580C Diagnosis of chronic myelogenous leukemia |
| 02/27/1995 | CA2130793A1 Heterocyclic thrombin inhibitors |
| 02/26/1995 | CA2130709A1 Porcine vasoactive intestinal peptide receptor |
| 02/26/1995 | CA2130386A1 Monoclonal antibodies specific for 5-dihydrotestosterone |
| 02/24/1995 | CA2130230A1 Sugar-modified interferon |
| 02/23/1995 | WO1995005604A2 Methods for the diagnosis of alzheimer's disease |
| 02/23/1995 | WO1995005481A1 Diagnostic method and therapy |
| 02/23/1995 | WO1995005480A2 Compositions and methods for detecting target nucleic acid sequences utilizing flanking sequence enzyme molecules |
| 02/23/1995 | WO1995005478A1 Human timp-3 |
| 02/23/1995 | WO1995005471A2 Method for stable transformation of plants |
| 02/23/1995 | WO1995005470A1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor |
| 02/23/1995 | WO1995005469A1 Human erythropoietin receptor fragment and antibodies thereto |
| 02/23/1995 | WO1995005468A1 Binding molecules containing at least an immunoglobulin constant domain with modified allotypic determinant |
| 02/23/1995 | WO1995005467A2 Chitinase, dna coding therefor and plants containing same |
| 02/23/1995 | WO1995005466A1 Models of alzheimer's disease |
| 02/23/1995 | WO1995005465A1 Erythropoietin analogs |
| 02/23/1995 | WO1995005464A1 B7-2: ctla4/cd28 counter receptor |